[ad_1]
Abu Dhabi: Global investment platform Investopia has unveiled one of the key outcomes of its annual conference in Abu Dhabi on 2-3 March: the launch of smart clinics in the UAE and the wider Middle East.
Smart cities are a new concept in healthcare that focuses on improving quality of life and establishing pathways to health. Technology and precision medicine are key components of the smart clinic initiative.
The announcement was made during the signing of the partnership with Italy’s GKSD Investment Holding Group and Gruppo San Donato (GSD), Italy’s leading private hospital group.
The MoU was signed during the Investopia meeting by Abdulla Al Saleh, Undersecretary of the Ministry of Economy, and Paolo Rotelli, Vice President of Gruppo San Donato, in the presence of Abdulla bin Touq Al Marri, UAE Minister of Economy and Chairman of Investopia.
GKSD Investment Holding and Gruppo San Donato have announced investments of more than EUR 125 million in new projects in the UAE and the region, including university infrastructure and smart clinics.
Abdulla Al Saleh said: “The main objective of the Investopia platform is to create a global investment system for new economies such as the healthcare technology industry. We are delighted to witness the launch of smart clinics in the UAE during the Investopia 2023 conference in partnership with GKSD Investment Holding and Gruppo San Donato.” Launch. This confirms the important role Investopia plays today as a global business destination where investors can meet and explore investment opportunities in the new economy.”
Kamel Ghribi, President of GKSD Investment Holding, said: “We are very proud of our strong capabilities in healthcare management and services, including acute care treatment, medical education, scientific research in the fields of gene and cell therapy, and most recently in artificial With the help of AI, the development of precision medicine has come a long way. We remain focused on expanding our collaboration in the MENA region, sharing our GKSD expertise.”
“Advances in gene therapy and editing, as well as technological innovations, have supported the development of precision medicine,” said Paolo Rotelli, president of San Rafael Life and Health University and vice president of Gruppo San Donato. Improving quality of life. At GKSD and Gruppo San Donato, our focus is on providing healthcare infrastructure and expertise aimed at improving quality of life by focusing on “pathways to health.” We are also working on AI-supported diagnostic procedures that There will be many benefits.”
[ad_2]
Source link